Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Cellular & Molecular Immunology (3)
Nature Medicine (2)
Blood Cancer Journal (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (4)
Amendments and Corrections (1)
Correspondence (1)

Subject Check one or more subjects to show results from those subjects only.

Cancer
Diseases
Immunology
Medical research
Oncology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–6 of 6 results

Advanced filters: Author: Morten Orebo Holmström Clear advanced filters

Author Correction: A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma

Julie Westerlin Kjeldsen
Cathrine Lund Lorentzen
Inge Marie Svane
Amendments and CorrectionsOpen Access08 Mar 2022
Nature Medicine

Volume: 28, P: 871
A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma

A first-in-class immune-modulating IDO/PD-L1-targeting vaccine combined with nivolumab in a phase 1/2 trial achieved very promising clinical activity and long-lasting immune responses in patients with advanced melanoma.

Julie Westerlin Kjeldsen
Cathrine Lund Lorentzen
Inge Marie Svane
ResearchOpen Access09 Dec 2021
Nature Medicine

Volume: 27, P: 2212-2223
The antitumor activity of TGFβ-specific T cells is dependent on IL-6 signaling

Maria Perez-Penco
Mikkel Byrdal
Mads Hald Andersen
ResearchOpen Access09 Dec 2024
Cellular & Molecular Immunology

Volume: 22, P: 111-126
Characterization of TGFβ-specific CD4⁺T cells through the modulation of TGFβ expression in malignant myeloid cells

Rasmus Erik Johansson Mortensen
Morten Orebo Holmström
Mads Hald Andersen
Correspondence15 Sept 2021
Cellular & Molecular Immunology

Volume: 18, P: 2575-2577
High frequencies of circulating memory T cells specific for calreticulin exon 9 mutations in healthy individuals

Morten O. Holmström
Shamaila M. Ahmad
Mads H. Andersen
ResearchOpen Access17 Jan 2019
Blood Cancer Journal

Volume: 9, P: 1-14
Cytotoxic T cells isolated from healthy donors and cancer patients kill TGFβ-expressing cancer cells in a TGFβ-dependent manner

Morten Orebo Holmström
Rasmus Erik Johansson Mortensen
Mads Hald Andersen
Research06 Jan 2021
Cellular & Molecular Immunology

Volume: 18, P: 415-426